ArticleChina CDC weekly2025
Identification of A Novel Human Adenovirus Type 114 Associated with An Acute Respiratory Disease Outbreak at An Elementary School - Beijing, China, September 2024.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
What is already known about this topic?: Recent years have witnessed increasing reports of acute respiratory outbreaks caused by novel recombinant human adenovirus (HAdV). In November 2023, researchers at the Medical University of Hannover in Germany identified HAdV-B114. What is added by this report?: The six strains of HAdV isolated in this outbreak were 100% homologous and also had the highest homology with the GenBank reference OR853835 for HAdV-B114 at 99.9%, 100%, and 99.8% in penton base gene hexon gene, and fiber gene. This is the first documented outbreak in China associated with HAdV-B114. What are the implications for public health practice?: Given that genetically recombined HAdVs can pose serious threats to human health and trigger emerging infectious disease outbreaks, continuous monitoring - particularly of novel recombinant types based onpenton base gene, hexon gene, and fiber gene sequences - should be prioritized to enable early detection and effective public health response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.